BiotechTube

Asciminib

Pre-clinicalActive
0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Chronic Myeloid Leukemia in Chronic Phase

Conditions

Chronic Myeloid Leukemia in Chronic Phase

Trial Timeline

— → —

NCT ID
NCT04360005

About Asciminib

Asciminib is a pre-clinical stage product being developed by Novartis for Chronic Myeloid Leukemia in Chronic Phase. The current trial status is active. This product is registered under clinical trial identifier NCT04360005. Target conditions include Chronic Myeloid Leukemia in Chronic Phase.

What happened to similar drugs?

20 of 20 similar drugs in Chronic Myeloid Leukemia in Chronic Phase were approved

Approved (20) Terminated (3) Active (0)
✅Pegasys® + Pegasys®Chugai PharmaceuticalApproved
✅Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mgYuhanApproved
✅placebo + aspirin + clopidogrel + aspirin OR prasugrel + aspirinDaiichi SankyoApproved
✅alefacept + polyvalent pneumococcal vaccineAstellas PharmaApproved
✅alefaceptAstellas PharmaApproved
✅AlefaceptAstellas PharmaApproved
✅lysozyme 90 mg + PlaceboEisaiApproved

Hype Score Breakdown

Clinical
3
Activity
12
Company
15
Novelty
0
Community
0

Clinical Trials (8)

NCT IDPhaseStatus
NCT04360005Pre-clinicalActive
NCT07250087Phase 1Recruiting
NCT06629584Phase 2Recruiting
NCT06427811ApprovedActive
NCT06236724Phase 2Recruiting
NCT05384587Phase 2Active
NCT04795427Phase 2Completed
NCT03605277Phase 1Completed

Competing Products

20 competing products in Chronic Myeloid Leukemia in Chronic Phase

See all competitors
ProductCompanyStageHype Score
Levofloxacin 500Dr. Reddy's LaboratoriesPre-clinical
23
mRNA-0184ModernaPhase 1
0
Lubiprostone + Lubiprostone + PlaceboDr. Reddy's LaboratoriesPhase 3
37
macitentan 10 mgBML, Inc.Phase 3
32
KPL-716 + PlaceboKiniksa PharmaceuticalsPhase 2
29
TERN-701Terns PharmaceuticalsPhase 1/2
36
Fludarabine + Cyclophosphamide + PRGN-3007PrecigenPhase 1
23
LY3556050 + PlaceboEli LillyPhase 2
35
THB001Third Harmonic BioPhase 1
11
BriquilimabJasper TherapeuticsPhase 1/2
26
BriquilimabJasper TherapeuticsPhase 1/2
14
BriquilimabJasper TherapeuticsPhase 2
29
Empagliflozin + Matching placeboEli LillyPhase 3
40
LY3461767 + PlaceboEli LillyPhase 1
29
Pirtobrutinib + Venetoclax + RituximabEli LillyPhase 3
44
LY3526318 + PlaceboEli LillyPhase 2
35
PirtobrutinibEli LillyPhase 2
42
Ibrutinib + LY3214996Eli LillyPhase 1
21
Pirtobrutinib + AcalabrutinibEli LillyPhase 2
27
LYR-210Lyra TherapeuticsPhase 2
25